Dose Dependent Course of Hyperprolactinemic and Normoprolactinemic Galactorrhea Induced by Venlafaxine.
10.9758/cpn.2017.15.2.181
- Author:
Mehmet Akif CAMKURT
1
;
Gizem GÜLPAMUK
;
Ebru FINDIKLI
;
Rengin ELVE
Author Information
1. Department of Psychiatry, Afşin State Hospital, Afşin, Turkey. dr.akif@gmail.com
- Publication Type:Case Report
- Keywords:
Venlafaxine hydrochloride;
Galactorrhea;
Prolactin;
Depression;
Therapeutics;
Management
- MeSH:
Depression;
Depressive Disorder, Major;
Female;
Galactorrhea*;
Humans;
Norepinephrine;
Pregnancy;
Prolactin;
Serotonin;
Venlafaxine Hydrochloride*
- From:Clinical Psychopharmacology and Neuroscience
2017;15(2):181-183
- CountryRepublic of Korea
- Language:English
-
Abstract:
Venlafaxine is a serotonergic and noradrenergic reuptake inhibitor which is used for the treatment of depression. We report a case of galactorrhea in a patient with major depressive disorder after starting treatment with venlafaxine. In particular, we discuss the course of hyper and normoprolactinemic galactorrhea. We managed this side effect initially by dose reduction and further by switching to essitalopram. Physicians should be aware of endocrinologic side effects such as galactorrhea during the serotonin and noradrenaline reuptake inhibitor treatment.
